Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2017 | 11-2016 | 08-2016 | 05-2016 | 02-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -563 | -259 | -55 | -1,500 | -274 |
| Depreciation Amortization | 164 | 111 | 53 | 232 | 175 |
| Income taxes - deferred | N/A | N/A | N/A | 703 | -254 |
| Accounts receivable | -162 | -193 | 1 | 151 | 201 |
| Other Working Capital | -47 | -174 | -60 | 322 | 129 |
| Other Operating Activity | 218 | 206 | -11 | -118 | -172 |
| Operating Cash Flow | $-389 | $-308 | $-72 | $-209 | $-195 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -96 | -26 | N/A | -92 | -70 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -4 | -1 |
| Other Investing Activity | 0 | 0 | 0 | -4 | -1 |
| Investing Cash Flow | $-96 | $-26 | $N/A | $-95 | $-71 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139 | N/A | N/A | 1,106 | 38 |
| Other Financing Activity | 0 | 57 | 0 | 0 | 0 |
| Financing Cash Flow | $139 | $57 | $N/A | $1,106 | $38 |
| Exchange Rate Effect | -1 | -1 | 0 | -1 | -1 |
| Beginning Cash Position | 1,889 | 1,889 | 1,889 | 1,088 | 1,088 |
| End Cash Position | 1,542 | 1,611 | 1,817 | 1,889 | 859 |
| Net Cash Flow | $-347 | $-278 | $-72 | $801 | $-229 |
| Free Cash Flow | |||||
| Operating Cash Flow | -389 | -308 | -72 | -209 | -195 |
| Capital Expenditure | -96 | -26 | N/A | -92 | -70 |
| Free Cash Flow | -485 | -334 | -72 | -300 | -265 |